This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Jul 13;142(2):124-126.

doi: 10.1182/blood.2023020566.

Challenging T-ALL to IL-7Rp dual inhibition

Carol Fries¹, Michelle L Hermiston²

Affiliations

PMID: 37440269
DOI: 10.1182/blood.2023020566

Free article

Editorial

Challenging T-ALL to IL-7Rp dual inhibition

Carol Fries et al. Blood. 2023.

Free article

. 2023 Jul 13;142(2):124-126.

doi: 10.1182/blood.2023020566.

Authors

Carol Fries¹, Michelle L Hermiston²

Affiliations

¹ University of Rochester.
² University of California San Francisco.

PMID: 37440269
DOI: 10.1182/blood.2023020566

No abstract available

PubMed Disclaimer

Comment on

IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition.
Courtois L, Cabannes-Hamy A, Kim R, Delecourt M, Pinton A, Charbonnier G, Feroul M, Smith C, Tueur G, Pivert C, Balducci E, Simonin M, Angel LH, Spicuglia S, Boissel N, Andrieu GP, Asnafi V, Rousselot P, Lhermitte L. Courtois L, et al. Blood. 2023 Jul 13;142(2):158-171. doi: 10.1182/blood.2022017948. Blood. 2023. PMID: 37023368

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems